Vimarsana
Biggest News Aggregation in the World

Page 11 - Genmark Diagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Genmark Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Genmark Diagnostics Today - Breaking & Trending Today

Syndromic Multiplex Diagnostic Market Analysis, Trends, Top Manufacturers, Share, Growth, Statistics, Opportunities & Forecast to 2028 | Abbott Laboratories, Akonni Biosystems, Inc., Applied BioCode, Inc, BioFire Diagnostics - Vimarsana News

Syndromic Multiplex Diagnostic Market Analysis, Trends, Top Manufacturers, Share, Growth, Statistics, Opportunities & Forecast to 2028 | Abbott Laboratories, Akonni Biosystems, Inc., Applied BioCode, Inc, BioFire Diagnostics

Syndromic Multiplex Diagnostic Market Analysis, Trends, Top Manufacturers, Share, Growth, Statistics, Opportunities & Forecast to 2028 | Abbott Laboratories, Akonni Biosystems, Inc., Applied BioCode, Inc, BioFire Diagnostics iCrowd Newswire Worldwide Syndromic Multiplex Diagnostic Market Analysis to 2027 is a specialized and in-depth study of the Syndromic Multiplex Diagnostic Market Industry with a focus on the global market trend. The report aims to provide an overview of global Syndromic Multiplex Diagnostic Market with detailed market segmentation by product/application and geography. ...

Coronavirus Testing Kits Market to See Huge Growth by 2026 | Altona Diagnostics, BioMednomics, CTK Biotech - Vimarsana News

Coronavirus Testing Kits Market to See Huge Growth by 2026 | Altona Diagnostics, BioMednomics, CTK Biotech

Coronavirus Testing Kits Market to See Huge Growth by 2026 | Altona Diagnostics, BioMednomics, CTK Biotech iCrowd Newswire Latest released the research study on Global Coronavirus Testing Kits Market, offers a detailed overview of the factors influencing the global business scope. Coronavirus Testing Kits Market research report shows the latest market insights, current situation analysis with upcoming trends and breakdown of the products and services. The report provides key statistics on the market status, size, share, growth factors of the Coronavirus Testing Kits. The study covers emerg...

Navigating the Choppy Waters of Implementing Rapid Molecular Blood Culture Identification Tests, Upcoming Webinar Hosted by Xtalks - Vimarsana News

Navigating the Choppy Waters of Implementing Rapid Molecular Blood Culture Identification Tests, Upcoming Webinar Hosted by Xtalks

Navigating the Choppy Waters of Implementing Rapid Molecular Blood Culture Identification Tests, Upcoming Webinar Hosted by Xtalks Share Article In this free webinar, the featured speakers will discuss how an Infectious Disease Specialist (IDS) can assist with the integration of rapid molecular blood culture identification into a laboratory’s current blood culture workflow. Discover how an IDS is well-positioned to assist in optimizing the use of rapid molecular blood culture identification and learn how they can help guide the development of result reporting workflows and institution-spec...

Source: prweb.com
COVID-19 Detection Test Kits And Consumables Market Faces Escalating Demand And Thereby, Ease Of Regulatory Processes - Vimarsana News

COVID-19 Detection Test Kits And Consumables Market Faces Escalating Demand And Thereby, Ease Of Regulatory Processes

COVID-19 Detection Test Kits And Consumables Global Market Report 2021: COVID-19 Implications And Growth To 2030 The Business Research Company’s COVID-19 Detection Test Kits and Consumables Global Market Report 2021: COVID-19 Implications And Growth To 2030 LONDON, GREATER LONDON, UK, May 12, 2021 /EINPresswire.com/ -- The escalating demand for cost-effective and quick COVID-19 detection kits coupled with the easing of regulatory processes for COVID-19 detection kits contributed to the growth of COVID-19 rapid test kits market. With the increasing incidence of COVID-19 (SARS-CoV-2) worldwid...

Q1 2021: A Look at Biopharma's Top 25 Companies by Market Cap - Vimarsana News

Q1 2021: A Look at Biopharma's Top 25 Companies by Market Cap

AbbVie announced Q1 results on April 30 that chairman and chief executive officer, Richard A. Gonzalez, described as “ahead of our expectations.” Blockbuster drug, Humira, led the way with global net revenues of $4.867 billion. The company recently took a hit as the suddenly cautious FDA extended its review of JAK inhibitor, Rinvoq (upadacitinib) for atopic dermatitis, requesting an updated assessment of its benefit-risk profile. This follows the news of a delay in the approval of Rinvoq for psoriatic arthritis. Rinvoq, which brought in $303 million globally this quarter, is one of the d...